11 Results

People

  1. Brentjens
    Brentjens
  2. Giralt
    Giralt
  3. Devlin
    Devlin
  4. Djaballah
    Djaballah
  5. Frattini
    Frattini
  6. Hassoun
    Hassoun
  7. Hsu
    Hsu
  8. Jurcic
    Jurcic
  9. Kelly
    Kelly
  10. Koehne
    Koehne

Groups

  1. Center for Hematologic Malignancies (11)
  2. Hematologic Malignancies Research (11)
  3. Department of Medicine (10)
  4. Hematologic Malignancies, Division of (10)
  5. GSK Faculty (8)
  6. Sloan Kettering Institute Faculty (6)
  7. Adult Leukemia (5)
  8. Bone Marrow Transplant (5)
  9. Tow Center for Developmental Oncology (TCDO) (4)
  10. Biostatistics Service (3)
  1. "Hematologic Malignancies Research"
  2. "Elsevier Inc."
  3. "2014"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
  3. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Hematologic Malignancies Research (11)
  3. Department of Medicine (10)
  4. Hematologic Malignancies, Division of (10)
  5. GSK Faculty (8)
  6. Sloan Kettering Institute Faculty (6)

More Groups

People
  1. Renier Brentjens (4)
  2. Sergio Giralt (4)
  3. Sean Devlin (3)
  4. Alexander Lesokhin (2)
  5. David Chung (2)
  6. David Scheinberg (2)

More People

Years
  1. 2014 (11)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (4)
  2. Biology of Blood and Marrow Transplantation (3)
  3. European Journal of Cancer (3)
  4. Leukemia Research Reports (1)
Publishers
  1. Elsevier Inc. (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the cell cycle regulated CDC7 kinase pathway as a novel therapeutic approach for hematologic malignancies
    Meeting Abstract

    Santos, R.; Shum, D.; Churchill, M.; Mukherjee, S.; Brentjens, R. J.; Jurcic, J. G.; Kelly, T.; Djaballah, H.; Frattini, M. G.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Inhibition of the cell cycle regulated Cdc7 kinase pathway is an efficacious therapeutic approach for hematologic malignancies and solid tumors
    Meeting Abstract

    Santos, R.; Shum, D.; Carrillo, D.; Zhang, R.; Churchill, M.; Mukherjee, S.; Brentjens, R.; Radu, C.; Kelly, T. J.; Djaballah, H.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Auxiliar treatment by targeting the extracellular matrix to improve drug delivery and therapeutic response
    Meeting Abstract

    Henke, E.; Roehrig, F.; Hoffmann, H.; Escorcia, F.; Wartenberg, M.; Volova, S.; Gaetzner, S.; Rosenwald, A.; Erguen, S.; Scheinberg, D. A.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Hsp90 pharmacoproteomics: Harnessing pieiotropy for therapeutic synergy
    Meeting Abstract

    Goldstein, R.; Chiosis, G.; Cerchietti, L. C.; Melnick, A. M.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • The road to treating smoldering multiple myeloma
    Conference Paper

    Korde, N.; Mailankody, S.; Landgren, O.
    Elsevier Inc. (2014)

    Fulltext@MSK | Save
  • Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells
    Journal Article

    Dickson, M. A.; Papadopoulos, E. B.; Hedvat, C. V.; Jhanwar, S. C.; Brentjens, R. J.
    Leukemia Research Reports (2014)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches
    Meeting Abstract

    Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Immune reconstitution after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Wu, V.; Hassoun, H.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Koehne, G.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save